CV
Cadrenal Therapeutics, Inc. Common Stock (CVKD)
NASDAQ·Healthcare·Biotechnology
$3.92
-2.85%
Mkt Cap $18.70M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$32.00
Range $32.00 – $32.00
Implied Upside
+717.4%
Consensus $32.00 vs current $3.92